Skip to content

Clinical trials

Phase 1/2 Esophageal Squamous Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 1/2 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20072
20131
20162
20173
20181
20191
20201
20213
20224
20236
20241
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16
Unknown status8
Completed7
Terminated3
Withdrawn2
Active, not recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AP Biosciences Inc.1
Alentis Therapeutics AG1
Astellas Pharma Global Development, Inc.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
DualityBio Inc.1
Federation Francophone de Cancerologie Digestive1
Hoffmann-La Roche1
InduPro, Inc.1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma40
Squamous Cell Carcinoma of Head and Neck13
Esophageal Neoplasms12
Carcinoma, Non-Small-Cell Lung8
Uterine Cervical Neoplasms5
Melanoma4
Small Cell Lung Carcinoma4
Carcinoma, Squamous Cell3
Colorectal Neoplasms3
Stomach Neoplasms3

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.